tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GLPG Stock Latest News

Galapagos to Wind Down Global Cell Therapy Operations and Close Five Sites
Company AnnouncementsGalapagos to Wind Down Global Cell Therapy Operations and Close Five Sites
7d ago
6K
GLPG
Galapagos initiates the wind-down of cell therapy activities
PremiumThe Fly
Galapagos initiates the wind-down of cell therapy activities
7d ago
GLPG
Galapagos Reports Mixed Late-Stage Results for TYK2 Inhibitor GLPG3667 and Eyes Partnerships After Dermatomyositis Win
PremiumCompany Announcements
Galapagos Reports Mixed Late-Stage Results for TYK2 Inhibitor GLPG3667 and Eyes Partnerships After Dermatomyositis Win
25d ago
6K
GLPG
Galapagos GALARISSO DM study meets primary endpoint, GALACELA SLE study misses
PremiumThe Fly
Galapagos GALARISSO DM study meets primary endpoint, GALACELA SLE study misses
25d ago
GLPG
Galapagos NV Announces Promising ATALANTA-1 Study Results Amid Plans to Wind Down Cell Therapy
PremiumCompany Announcements
Galapagos NV Announces Promising ATALANTA-1 Study Results Amid Plans to Wind Down Cell Therapy
1M ago
6K
GLPG
Galapagos announce new ATALANTA-1 study data at ASH meeting
PremiumThe FlyGalapagos announce new ATALANTA-1 study data at ASH meeting
1M ago
GLPG
Galapagos NV: Strategic Shift to Investment Entity Warrants Hold Rating Amid Opportunities and Risks
Premium
Ratings
Galapagos NV: Strategic Shift to Investment Entity Warrants Hold Rating Amid Opportunities and Risks
2M ago
GLPG
Galapagos NV Receives Transparency Notifications from Bank of America
Premium
Company Announcements
Galapagos NV Receives Transparency Notifications from Bank of America
2M ago
6K
GLPG
Galapagos initiated with a Market Perform at Bernstein
PremiumThe Fly
Galapagos initiated with a Market Perform at Bernstein
2M ago
GLPG
Galapagos price target raised to $32 from $28 at RBC Capital
PremiumThe Fly
Galapagos price target raised to $32 from $28 at RBC Capital
2M ago
GILD
GLPG
Galapagos NV Reports Strategic Shift and Financial Results
PremiumCompany Announcements
Galapagos NV Reports Strategic Shift and Financial Results
2M ago
GLPG
Galapagos NV Earnings Call: Strategic Shifts Amid Challenges
PremiumCompany Announcements
Galapagos NV Earnings Call: Strategic Shifts Amid Challenges
2M ago
GLPG
Galapagos NV to Wind Down Cell Therapy Business Amid Strategic Shift
PremiumCompany AnnouncementsGalapagos NV to Wind Down Cell Therapy Business Amid Strategic Shift
2M ago
6K
GLPG
Galapagos to Present Promising CAR-T Cell Therapy Data at ASH 2025
Premium
Company Announcements
Galapagos to Present Promising CAR-T Cell Therapy Data at ASH 2025
2M ago
6K
GLPG
GLPG Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
GLPG Upcoming Earnings Report: What to Expect?
2M ago
GLPG
Galapagos NV Strengthens Board with Strategic Appointments
PremiumCompany Announcements
Galapagos NV Strengthens Board with Strategic Appointments
2M ago
6K
GLPG
Galapagos price target raised to $28 from $27 at RBC Capital
PremiumThe Fly
Galapagos price target raised to $28 from $27 at RBC Capital
3M ago
GILD
GLPG
Leerink upgrades Galapagos on confidence after cell therapy exit
PremiumThe Fly
Leerink upgrades Galapagos on confidence after cell therapy exit
3M ago
GLPG
Galapagos upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Galapagos upgraded to Outperform from Market Perform at Leerink
3M ago
GLPG
Galapagos NV to Wind Down Cell Therapy Business Following Strategic Review
PremiumCompany AnnouncementsGalapagos NV to Wind Down Cell Therapy Business Following Strategic Review
3M ago
6K
GLPG
Galapagos intends to wind down cell therapy business
Premium
The Fly
Galapagos intends to wind down cell therapy business
3M ago
GILD
GLPG
Galapagos Appoints Fred Blakeslee as General Counsel
Premium
Company Announcements
Galapagos Appoints Fred Blakeslee as General Counsel
3M ago
6K
GLPG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >